Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you take more than 400 MG of Bextra a day?

Have any of the following side effects occurred? (Please check all that apply.)

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

HSA Suspends Sales of Pfizer's Bextra in Singapore

Apr 8, 2005 | Channel NewsAsia

Singapore has suspended the sales of Bextra, an anti-inflammatory drug produced by the global pharmaceutical manufacturer Pfizer.

Study shows that taking Bextra may pose risk to patients' cardiovascular safety or incur rare but serious skin reactions, which have led to similar bans on the drug in the United States, the European Union and Canada.

The Health Sciences Authority (HSA) of Singapore confirmed thatno local case of serious skin reactions had been reported, but it advised patients taking the drug to consult their doctors for alternative treatments.

Commonly used to treat osteoarthritis or rheumatoid arthritis, Bextra has entered Singapore market since May 2003 to deal with acute pain, the report said. Enditem

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo